Hap Trading, LLC Bridge Bio Pharma, Inc. Transaction History

Hap Trading, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$27.35 - $40.45 $1.04 Million - $1.54 Million	38,039 New	38,039 $1.18 Billion
Q2 2023 Aug 11, 2023	BUY	$13.29 - $18.01 $748,133 - $1.01 Million	56,293 New	56,293 $968,000
Q4 2021 Feb 14, 2022	BUY	$11.38 - $53.41 $4.39 Million - $20.6 Million	385,940 Added 573.19%	453,272 $7.56 Million
Q3 2021 Nov 10, 2021	BUY	$46.87 - $64.24 $1.42 Million - $1.94 Million	30,253 Added 81.59%	67,332 $3.16 Million
Q2 2021 Aug 11, 2021	SELL	$46.47 - $63.93 $135,320 - $186,164	-2,912 Reduced 7.28%	37,079 $2.26 Million
Q1 2021 May 14, 2021	BUY	$55.47 - $72.35 $2.22 Million - $2.89 Million	39,991 New	39,991 $2.46 Million

294

170M

10.4M

2.36M

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $5.57B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.